Cargando…
Benefits and harms of lung cancer screening in HIV-infected individuals with CD4(+) cell count at least 500 cells/μl
OBJECTIVE: Lung cancer is the leading cause of non-AIDS-defining cancer deaths among HIV-infected individuals. Although lung cancer screening with low-dose computed tomography (LDCT) is endorsed by multiple national organizations, whether HIV-infected individuals would have similar benefit as uninfe...
Autores principales: | Kong, Chung Yin, Sigel, Keith, Criss, Steven D., Sheehan, Deirdre F., Triplette, Matthew, Silverberg, Michael J., Henschke, Claudia I., Justice, Amy, Braithwaite, R. Scott, Wisnivesky, Juan, Crothers, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991188/ https://www.ncbi.nlm.nih.gov/pubmed/29683843 http://dx.doi.org/10.1097/QAD.0000000000001818 |
Ejemplares similares
-
Prognosis in HIV-infected patients with non-small cell lung cancer
por: Sigel, K, et al.
Publicado: (2013) -
Reply: Early Adherence to Lung Cancer Screening
por: Triplette, Matthew, et al.
Publicado: (2021) -
Clinically significant mutations in HIV-infected patients with lung adenocarcinoma
por: Thaler, Jonathan, et al.
Publicado: (2017) -
Cost-effectiveness of pembrolizumab for advanced non-small cell lung cancer patients with varying comorbidity burden
por: Criss, Steven D., et al.
Publicado: (2020) -
Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities
por: Sigel, Keith, et al.
Publicado: (2021)